NCT03907215View on ClinicalTrials.gov

A Clinical Study to Examine the Drug-drug Interactions Between ACT-541468 and Citalopram in Healthy Male and Female Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 9, 2019

Primary Completion Date

June 26, 2019

Study Completion Date

June 26, 2019

Conditions
Healthy
Interventions
DRUG

ACT541468

50 mg; film-coated tablet for oral use

DRUG

ACT541468 placebo

film-coated tablet for oral use

DRUG

Citalopram

20 mg; tablet tor oral use; for single- or repeated dosing

Trial Locations (1)

14050

Parexel International GmbH, Berlin

Sponsors
All Listed Sponsors
lead

Idorsia Pharmaceuticals Ltd.

INDUSTRY

NCT03907215 - A Clinical Study to Examine the Drug-drug Interactions Between ACT-541468 and Citalopram in Healthy Male and Female Subjects | Biotech Hunter | Biotech Hunter